About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | HIV/AIDS Clinical Trials | 1,628 Studies Recruiting

Clinical TrialsHIV/AIDS

HIV/AIDS Clinical Trials

Browse 1,628 clinical trials for hiv/aids. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1321-1340 of 1,628 trials

UnknownSOLFAMU Study of Nasal Brushing Collected OLFActory MUcosa Samples in the Diagnosis of Human EncephalopathiesEncephalopathies are a group of central nervous system (CNS) affection with heterogeneous etiology.NCT02951559·Torino CompletedStudy to Evaluate a HIV Drug for the Treatment of HIV InfectionThe primary purpose of this study is to study the safety and tolerability of a HIV drug and to evaluate a decrease of HIV-1 virus level in blood after treatments in HIV-1 infected…NCT01803074·Berlin Not yet recruitingProject SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven ProtocolProject SPEED (Streamlined Protocol for Early Engagement and Delivery of HIV Prevention) is a pragmatic, cluster randomized implementation study evaluating a nurse-driven model…NCT07346508

Related Searches

aidstrials human immunodeficiencytrials

Data from ClinicalTrials.govTerms

RecruitingImaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment InterruptionBackground: Human immunodeficiency virus (HIV) infects CD4 T cells. There is no cure for HIV.NCT05419024·Bethesda, Maryland

CompletedA Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult ParticipantsAn open-label, two part study to assess the safety, tolerability, and PK of VH3810109 in healthy adult participants.NCT05291520·Austin, Texas

CompletedAntiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS StudyThe aim of this study is to develop and follow a cohort of human immunodeficiency virus (HIV)-infected adults who are starting HIV drugs at health facilities in Kenya.NCT02027480·Ahero, Nyanza and 8 others

CompletedDose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy AdultsBackground: HIV stands for human immunodeficiency virus, which is the virus that causes AIDS. There is currently no licensed vaccine to prevent HIV infection.NCT03783130·Bethesda, Maryland

CompletedSafety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral TherapyThe purpose of this study is to assess the safety and efficacy of tenofovir disoproxil fumarate (tenofovir DF; TDF) plus a genotype-guided optimized background regimen (OBR)…NCT00352053·Belo Horizonte - MG and 17 others

WithdrawnA Study of Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)The primary objective of this study is to evaluate the safety and tolerability of Islatravir (ISL) in trans and gender diverse (TGD) participants who are receiving…NCT05130086

CompletedA Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European CountriesThe overall objective of the CAB LA + RPV LA clinical development program is to develop a highly effective, well-tolerated, two-drug, LA injectable regimen which has the potential…NCT04399551·Antwerp and 17 others

TerminatedA Sleep Program to Improve Sleep Quality in People With HIVSleep problems, such as insomnia, are more frequent and intense in individuals living with HIV.NCT02571595·Montreal, Quebec

Completed48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV InfectionThis is a 48-week study to collect information on the safety and activity of an investigational medicine in patients, ages 2 to 18 years old, with HIV infection .NCT00089583·Birmingham, Alabama and 38 others

CompletedTenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected SubjectsThe purpose of Study GS-01-934 was to assess the efficacy and safety of two simplified antiretroviral treatment (ART) regimens in ART-naive, human immunodeficiency virus, type 1…NCT00112047·Beverly Hills, California and 4 others

CompletedContextualizing & Responding to HIV Risk BehaviorsThe purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based…NCT03300908·New York, New York

CompletedNitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected SubjectsInfection with hepatitis C virus (HCV) can cause liver scarring, or cirrhosis, and this usually occurs more rapidly among people infected with both HCV and human immunodeficiency…NCT00991289·Birmingham, Alabama and 17 others

CompletedPlatelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV InfectionHIV infection is associated with an immune activation and an inflammatory response - despite an active antiretroviral therapy - which may lead notably but not exclusively to…NCT02532348·Saint-Etienne

CompletedStudy of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral TherapyBackground: \- The human immunodeficiency virus (HIV) causes acquired immune deficiency syndrome (AIDS). Combination antiretroviral therapy (ART) drugs treat HIV infection.NCT01976715·Bethesda, Maryland

CompletedFrequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in JapanFollowing guidelines issued by the Centers for Disease Control, the Clinical Center implemented a Universal Precautions policy in November 1987 in an attempt to reduce healthcare…NCT00001712·Bethesda, Maryland

CompletedImmune Response to Influenza Vaccine in HIV-Infected IndividualsThis study will evaluate how HIV infection, including CD4 cell count and viral load, affects the patient's ability to produce antibodies in response to vaccination with the…NCT00069914·Bethesda, Maryland

CompletedOpen-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionHIV/Tuberculosis (TB) co-infection have profound effects on the host's immune system. TB is the most common cause of death in patients with HIV worldwide.NCT02178592·Ciudad de Buenos Aires, Buenos Aires and 27 others

PreviousPage 67 of 82Next